(Q34577948)

English

The impact of aggressive debridement used as an adjunct therapy with terbinafine on perceptions of patients undergoing treatment for toenail onychomycosis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

The impact of aggressive debridement used as an adjunct therapy with terbinafine on perceptions of patients undergoing treatment for toenail onychomycosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

0 references

author name string

Lori P Potter

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Susan D Mathias

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Monika Raut

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Farid Kianifard

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Adam Landsman

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Amir Tavakkol

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

1 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Journal of Dermatological Treatment

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

46-52

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

The effect of toenail onychomycosis on patient quality of life.

1 reference

https://api.crossref.org/works/10.1080%2F09546630600965004

21 January 2018

Quality of life of persons with onychomycosis.

1 reference

https://api.crossref.org/works/10.1080%2F09546630600965004

21 January 2018

Onychomycosis is more than a cosmetic problem

1 reference

https://api.crossref.org/works/10.1080%2F09546630600965004

21 January 2018

A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis

1 reference

https://api.crossref.org/works/10.1080%2F09546630600965004

21 January 2018

Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study

1 reference

https://api.crossref.org/works/10.1080%2F09546630600965004

21 January 2018

Onychomycosis. Baseline results of an observational study.

1 reference

https://api.crossref.org/works/10.1080%2F09546630600965004

21 January 2018

A health-related quality of life measure for use in patients with onychomycosis: a validation study

1 reference

https://api.crossref.org/works/10.1080%2F09546630600965004

21 January 2018

The impact of onychomycosis on quality of life: development of an international onychomycosis-specific questionnaire to measure patient quality of life.

1 reference

https://api.crossref.org/works/10.1080%2F09546630600965004

21 January 2018

Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in ONychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial

1 reference

https://api.crossref.org/works/10.1080%2F09546630600965004

21 January 2018

The OnyCOE-t questionnaire: responsiveness and clinical meaningfulness of a patient-reported outcomes questionnaire for toenail onychomycosis

1 reference

https://api.crossref.org/works/10.1080%2F09546630600965004

21 January 2018

Identifiers

10.1080/09546630600965004

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34577948&oldid=1960611029"